The nuclear pore complex (NPC) mediates macromolecular exchange between nucleus and cytoplasm. It is a regulated channel whose functional properties are modulated in response to the physiological status of the cell. Identifying the factors responsible for regulating NPC activity is crucial to understand how intracellular signaling cues are integrated at the level of this channel to control nucleocytoplasmic trafficking . For proteins lacking active translocation signals the NPC acts as a molecular sieve limiting passage across the nuclear envelope (NE) to proteins with a MW below -40 kD. Here, we investigate how this permeability barrier is altered in paradigms of cell death and cell survival, i.e., apoptosis induction via staurosporine, and enhanced viability via overexpression of BcI-2. We monitor dynamic changes of the NPC's size-exclusion limit for passive diffusion by confocal time-lapse microscopy of cells undergoing apoptosis, and use different diffusion markers to determine how BcI-2 expression affects steady-state NE permeability. We show that staurosporine triggers an immediate and gradual leakiness of the NE preceding the appearance of apoptotic hallmarks. BcI-2 expression leads to a constitutive increase in NE permeability, and its localization at the NE is sufficient for the effect, evincing a functional role for BcI-2 at the nuclear membrane. In both settings, NPC leakiness correlates with reduced Ca 2 + in internal stores, as demonstrated by fluorometric measurements of ER/NE Ca 2 + levels. By comparing two cellular models with opposite outcome these data pinpoint ER/NE Ca 2 + as a general and physiologically relevant regulator of the permeability barrier function of the NPC.
Introduction
In eukaryotic cells the nuclear envelope (NE) provides a physical barrier that secludes and organizes genomic material within the nucleus. Molecular traffic across th e NE occurs exclusively via nuclear pore complexes (NPCs) , multimeric macromolecular channels spanning both lipid layers of the NE.
The NPC acts as diffusion barrier for inert molecules with a MW larger than = 40 kD and facilitates the translocation of much larger proteins up to a flux rate of 1000Is.' This activity is dynamically regulated in response to physiological or pathological signaling cues.2.3 Functional control of the NPC may occur via alterations in NPC composition 4 , by post-translational modification of nuclear pore proteins (Nups),5.G and by modulating the dimensions of the channel itself.? These structural changes impinge on transport capacity and selectivity of the NPC as well as on its size-exclusion limit for passive translocation. Thus, one important layer of regulation of nucleo-cytopl asmie trafficking resides at the NPC itsel f'll. Active cell proliferation and programmed cell death are examples for cellu lar states known to induce modifications of NPC structure and function. Oncogene-transformed, ' Correspondence to: Elisa Ferrando-May; Emai l: elisa.may@uni -konstanz.de hyperproliferating cells display larger NPC diameters than their resting counterparts. 9 ,'o In mitotic cells, the level of Nup96 is downregulated to allow efficient GI /5 transition. 1I In apoptotic cells, NPC dismantling and breakdown of the NE permeability barrier are the consequence of caspase-mediated proteolysis of a subset of nUcleoporins (NupS).I2·,G Yet another study has evidenced that calpains, Ca 2 '-activated proteases, cleave Nups in neuronal cells undergoing excitotoxic death resulting in nuclear accumulation of the cytoplasmic protein GAPDH. ' 7 Disruption of NPC components is not the only mechanism of NE permeabilization, since nuclea r leakiness has been observed also in the absence of Nup proteolysis in apoptotic and virus-infected cells.' 2. 17. IB Also the proapoptotic Bcl-2 family proteins Bax and Bak were proposed to affect nucleo-cytoplasmic protein partitioning: histone HI and nucleophosmi n were shown to redistribute to the cytoplasm as a conseq uence ofBax/Bak overexpress ion independently of caspase activity.'9 This result high lights yet another li nk between the apoptosis machinery and nucleo-cytoplasmic trafficking.
Ca 2 • functions as second messenger in the cellular response to very diverse endogenous and exogenous signals ranging from noxious environmental insults to growth stimulatory factors. Staurosporine induces a pre-apoptotic, caspase-independent leakiness of the NE. We first investigated how STS treatment affects the permeability barrier function of the NE. To this end, we performed single-cell, confoca l time-lapse recordings of HeLa cells expressi ng a reporter for passive passage across the NE, a tetrameric mCherry fusion protein (4xCherry) ( Fig. lA and B ; Fig. SIA and B ). Images were taken approx. every 8 min, and a minimum of 13 cells was recorded in each experiment. T he nucl ea r inAux of 4xCherry was quantified over time as described in "Materials and Methods" and in Figure SID . To monitor apoptosis progression the cel ls were stained with low concentrations of the vital DNA dye Hoechst 33342. This enabled to visualize nuclear condensation as a h a llmark of caspase-dependent apoptot ic execution (Fig.  SIC) . To account for the asynchronicity of the apoptotic process, data from each time series were split into two parts and displayed ----
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on separate x-axes. The left portion of the x-axis shows traces from the start of the experiment up to time points immediately preceding nuclear condensation (pre-apoptotic) . On the right x-axis, traces were aligned with respect to the time of nuclear condensation (time point 0) . This arrangement properly visualizes changes in nuclear permeability occurring at nuclear execution. cence displayed a characteristic early-onset and gradual increase in signal intensity indicating that nuclei became partially access ible to the permeability marker shortly after drug addition ( ated with apoptotic cell demise we treated cells with TRAIL, a death receptor ligand triggering cell death via the extrinsic pathway.38 Cells underwent apoptosis quite rapidly as expected (~I.5h) but in contrast to STS treatment nuclei efficiently excluded 4xCherry until chromatin condensation ensued (Fig. lA, open circles, left x-axis). In the final phase, the NE permeability barrier collapsed in these cells simi larly to STS-treated cells (Fig.  lA , right x-ax is). These data suggest that the observed pre-apoptotic increase in nuclear access ibility is a distinctive feature of STS-induced cell death. To address the question about a potential involvement of Ca (Fig. IC,  D) . These results suggest that the early increase in the size exclusion limit of the NE for passive diffusion observed under STS treatment is associated with the depletion of ER/N E [Ca 2 . ] levels induced by this drug.
Early NE leakiness precedes apoptotic cleavage of nucleoporin Nupl53 and is not dependent on caspase activity. According to previous studies, collapse of the nucleocytoplasmic permeability barrier in apoptosis is brought about by the caspase-mediated cleavage ofNups.14 To temporally correlate the permeability alterations of the NE observed in STS-and TRAILtreated cells wit h NPC proteolysis we monitored a fluorescently labeled fusion of Nup153 over time. Nup153 is a component of the N PC located at the nuclea r basket and is effi ciently cleaved by execut ioner caspases. 12 . 16 In control experiments we verified that the NupI53 -GFP fusion protein is processed upon treatment of HeLa cells with STS or TRAIL in a caspase-dependent fashion (Fig. S2 ). In our confocal time series of apoptotic cells we then quantifid the average intensity of th e NupI53-GFP signal at the nuclear rim by manual segmentation, taking care to avoid regions in which the NE formed convolutions, as seen quite frequently in STS-treated cells. Such convolutions appear as outof-focus regions of the nuclear rim signal (Fig. SID) . Both STS and TRAIL treated cells showed a clear and abrupt reduction of NupI53-GFP fluorescen ce at the nuclear rim at the onset of chromatin condensation. This effect was abrogated in the presence of the pan-caspase inhibitor zVAD and by inactivation of the caspase cleavage site in Nup153 at amino acid position 349 (Fig. 2 , right x-axes). In the time window preceding chromatin condensation, NupI53-GFP traces were quite similar for STS and TRAIL treatment and both were not affected by zVAD (Fig.  2, left axes) . According to these data, loss of NupI53-GFP signal from the nuclear rim is an indicator of caspase-dependent dismantling of the NPC which occurs concomitantly to chromatin condensation. We then investigated the effect of zVAD on the kinetics of nuclear 4xCherry influx. Caspase-inhibition prevented the final, abrupt collapse of the permeability barrier in both apoptosis models, but had no effect on the early-onset, moderate increase in nuclear accessibi li ty observed in cells treated with STS (Fig. 3A) . In these cells caspase-3-like activity was not detectable until 2h after stimulation, when partial nuclea r entry of 4xCherry was already established. This assay also confirmed that zVAD was highly effective in blocking caspase activation (Fig. 3C ). In sum, these results support the existence of an early, caspase-independent leakiness of the NE that precedes the apoptotic dismantling of the NPC triggered by STS.
Early pre-apoptotic permeabilization of the nuclear envelope depends on Ca 2 ., but not on calpain activation. The NPC has been shown to be the target of non-caspase proteolytic systems, in particular of the Ca 2 '-dependent protease family of ca lpains. 
Exogenous expression of Bcl-2 at the nuclear membrane increases NE permeability. Bcl-2 is an antiapoptotic protein with potent pro-survival activity whose exp ressio n leads to a reduction in ER/NE Ca 2 • levels. 41 Bcl-2 family pro-
teins Bax and Bak have been suggested to increase nuclear permeabilityl9 as part of their proapoptotic activity. Their antiapoptotic cousin Bcl-2 has not been investigated so far. Therefore we sought To investigate the potential involvement of calpains in STSmediated nuclear permeabilization in HeLa cells we performed live-cell microscopy experiments in the presence of the cell-permeable calp ain inhibitor calpeptin . The efficacy of the inhibitor was confirmed using an in vitro calpain activity assay (Fig.  S3 ). Differendy from neuronal excitotoxicity, calpeptin did not protect from NE permeability changes induced by STS in HeLa cells both on the ea rly and late time scale (Fig. 3B ). Early nuclear leakiness, however, was efficien tly prevented in the presence of BAPTA-AM, a cell permeable, high-affinity Ca 2 • chelator that removes intracellular free [Ca 2 .] also in internal stores. 40 In the presence of BAPTA-AM mobilization of free [Ca 2 .] from the ER/NE is blocked. This compound did not inhibit the collapse of the NE permeability barrier occurring at nuclear condensation (Fig. 3B ). In addition, up to 2h after treatment with STS caspase-3-like activity was not significandy affected eithtr by ca lp eptin or by BAPTA-AM (Fig. 3C ) . This lack of correlation between caspase activation and the early nuclear redistribution of 4xCherry 4 labeled 70 kD dextran, and imaged by confocal microscopy. Passage of dextran across the NE was quamified by measuring the average fluorescence signal intensity in cell nuclei. In both HeLa and SW480 cells, Bcl-2 expression led to a marked increase in dextran nuclear entry as compared with control (Fig. 4A ). This finding was confirmed with transient transfections of HeLa-mBcl-2 cells using the permeability marker 4xCherry. Cells with a homogenously distri buted fluorescence signal were scored positive for nuclear 4xCherry. Bcl-2 expression resulted in a significan tly higher percemage of these cells as compared with control (Fig. 4B) . Finally, we used bead loading co introduce fluore sctnt 70 kD dc::xtran imo Bcl-2 overexpressing HeLa cells, and obtained again similar resuirs (Fig.  S4B) . Airogether these data demonstrate that overexpression of Bcl-2 leads to an increase in the size exclusion limit of the NE for passive diffusion, a finding quite unexpected from previous studies and from our own data linking nuclear leakiness to apoptotic cell death.
Bcl-2 is known to insert into all intracellular membranes including those of mitochondria, endopl asmic reticulum and nucleus (own unpublished observations and ref. 44 ). To exam in e whether the effect of Bcl-2 on the nuclear permeabi lity barrier depc::nds on the specific subcd lular loca li zation of this protein we compared nuclear entry of 4xCherry in cells expressing full length Bcl-2, and Bcl-2 variants targeted either to the endoplasmic reticulum via fusion to the C-terminus of cytochrome b5 (ER-mBcl2 45 ), or to the mitochondria (mito-mBcl2 46 ) or to the NE (NE-mBcl2, this study). The latter Bcl-2 variant was generated by replacing the C-terminal transmembrane domain of Bcl-2 with the KASH domain of human Nesprin-2, a protein tethering the actin cytoskeleton to the nuclear membrane 47 ( Fig.  S5A) . At high expression levels NE-mBcl2 showed a tendency to mislocalize to the ER (not shown) . We therefore expressed the corresponding gene under the control of a tetracycline-regulatable promoter in HeLa Tet Off cells. At low expression levels we cou ld achieve an exclusive localization ofNE-Bcl2 at the nuclear rim, as judged by its colocalization with Nesprin-2 in confocal images (Fig. S5B) . HeLa cells were transiently transfected with plasmid vectors encoding wildtype, mitochondrial, and ER targeted Bcl-2 . NE-targeted Bcl-2 was expressed in HeLa Tet Off cells in the presence of doxycyclin. N E-targeted GFP served as control. Nuclear permeability was assessed by contrasfection of 4xCherry and counting cells with equal distribution of the permeability marker between nucleus and cytoplasm. Bcl-2 localization was verified via immunocytochemistry. An increase in N E permeability comparable to that caused by wildtype Bcl-2 was obtained only in cells in which Bcl-2 locali zed at the ER and the NE but not at the mitochondria. We observed a 2-fold increase with respect to control cells expressing only the permeability marker (Fig. 5A , B and C). These data indicate that localization of Bcl-2 at the NE is sufficient to mediate its activity on the nuclear permeability barrier.
Bcl-2 effects at the NE are mediated by Ca 2 • • The effect of Bcl-2 as regulator ofER Ca 2 ' levels is well documented (reviewed in 48). Based on our observation in STS-treated HeLa cells suggesting that Ca 2 • is involved in controlling the size exclusion limit of the NE, and havi ng detected that nuclear membraneassociated Bcl-2 might increase this limit, we inferred a role for Ca 2 • as downstream mediato r of Bcl-2 at the N E. To address this question, we first determined ER/NE Ca 2 • levels in Bcl-2-expressing cells using Fluo-4 and TG. Hela cells stably expressing wildtype Bcl-2 showed a marked reduction in TG-induced Ca 2 • release from internal stores as compared with control cells, in line with previous studies 41 (Fig. 6A and B is added back to the cultu re medium. 49 In Bcl-2 overexpressing cells, this response was shown to be downregulated as adaptation to the long-term reduction of Ca 2 • in their internal stores. 50 Readdition of Ca 2 • (1 mM) to HeLa cells previously exposed to TG evoked a steep increase in flu orophore signal indicative of Ca 2 • capacitative influx. This effect was significantly diminished in Bcl-2 overexpressing cells (Fig. 6A and B, right panel, left bar) . T hese data confirm that Bcl-2 overexpression leads to altered Ca 2 ' levels in the ER/N E supporting our ass umption of a role of Ca 2 • in the Bcl-2-dependent increase in NE permeability in our experimental model. We then sought to mimic the Ca .'!l (Fig. 6A and B, both panels, right bars). Analysis of nucleo-cytoplasmic 4xCherry distr ibution after adaptatio n to low calcium conditions indicated a signifi cant increase in the number of cells with nuclear 4xCherry, although not to the same extent as foll owing Bcl-2 overexpression (Fig. 6C) 51 In line with our working hypothesis, SERCA2 effectively counteracted the BcI-2 induced increase in nuclear permeability further implicating ERI NE Ca 2 • levels in the Bcl-2-dependent regu lation of NE permeability ( Fig. 7A and B) . .. Figure 5 . BcI-2localization at the nuclear membrane is sufficient to increase the size excl usion limit of the NE. (A) Confocal imag es of HeLa cells transiently expressing the permeability marker 4xCherry alone (control) and in combination with either wildtype murine bcl' 2 (wt-mBcI-2) or bcl-2 variants targeted to the mitochondria (mito-mBcI -2) and the endoplasmic reticulum (ER-mBcI-2). Nuclear envelope targeted BcI-2 (NE-mBcI -2) was expressed in HeLa Tet Off cells in the presence of 1 IJ.g/ml doxycyclin to avoid strong overexpression and mislocalization. Nuclear envelope targeted GFP (NE-GFP) served as control. BcI-2 localization was determined by immunocytochemistry using antibodies specific for murine BcI -2. The NE-Bcl 2 protein was not detectable at the nuclear rim under fixation conditions required to preserve 4xCherry localization. NE-BcI-2 expressing cells were nevertheless readily identifiable by a punctuate staining pattern. Proper local ization of NE-Bcl2 was verified in parallel transfection experiments using digitonin as a permeabilizing agent (see Supplemental Figure 5 and Material and Methods). Red: 4xCherry; Green: mBcI -2; Blue: DNA (Hoechst 33342). (B) and (C) Quantitation of microscopic images obtained from HeLa cells (B) and from HeLa Tet Off ce ll s (C). Cells expressing mBcI -2 and its variants were inspected for nuclear 4xCherry localization as described in Figure 4 . At least 150 cells per experimenta l condition were counted." p < 0.01 . In HeLa Tet off ce lls, expression of NE-targeted mBcI-2 resulted in a 2-fo ld increase in the number of cells displaying nuclear 4xCherry localization with respect to control cells. For wt mBcI-2 this increase was 2A-fo ld .
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expression. 52 . 53 The present work focuses on the NPC's activity as molecular sieve and investigates how th is functional parameter is affected by a drug treatment triggering cell death, vs. a condition of increased cell survival and proliferation. In both settings we detect an increase in the size-exclusion limit of the NPC and show data indicating Ca 2 • as a common mediator of the effect.
In STS-treated cells, we detect an early, pre-apoptotic leakiness of the NE concomitantly to a decrease in NEIER Ca 2 • levels. The effect is efficiently suppressed by a Ca 2 • chelator and mimicked by artificial downregulation of [Ca 2 . ] in internal stores. It is well establishe d that Ca 2 • release channels, such as IP3Rs and RyRs, carry multiple phosphorylation sites and that phosphorylation status modulates channel activity. To date at least 12 kinases are known to directly phosphorylate the IP3Rs.54 Treatment with STS, a pan-kinase inhibitor with broad substrate specificity55 may thus directly interfere with Ca 2 • homeostasis by altering Ca 2 . channel activity. The association of the IP3R inhibitory protein, IRBIT, to IP3Rs is also regulated by phosphorylation. 56 Dephosphorylated IRBIT, which might predominate in kinase-inhibited cells, cannot bind to IP3R. As a consequence, the receptor becomes sensitive to IP3 concentrations that ex ist in cells under resting conditions, which might result in a lower threshold for Ca 2 • release from the NEIER.
Ca 2 • leakage from the ER of
In sum, these data show that BcI-2 overexpression lowers the size excl usion limit of the nuclear envelope by altering Ca 2 • homeostasis at the ER/NE, and that locali zation of the protein at the nuclear membrane is sufficiem for the effect. apoptotic cells has also been shown to result from caspase-3 dependent cleavage ofIP3Rs, generating a constitutively leaky "channel-only" domain . 57 The latter however, represe nts a late apoptotic event downstream of caspase activation 58 which is diffi cult to reconci le with the ea rly-stage nuclear permeabilization observed here, occurring almost immediately after exposure to STS and prior to the caspase-mediated cleavage of Nups. We can also rule out the involvement of calpain-mediated NPC proteolysis in our system, contrarily to what has been reported in neurons challenged with high-doses of glutamate to trigger excitotoxic cell death.
Discussion
The idemification of general mechan isms that gove rn NPC activity in response to different extra-and intracell ular signaling cues is of prime importance for understanding the NPC's recognized involvement in basic nuclear functions, not only nucleo-cytoplasmic traffickin g but also chrom atin organ ization and gene 6 Our data do not support hyperp hosp horylation of Nup62 as being involved in the STS-dependent early nuclea r leakiness.
Nup62, a heavi ly O-glycosylated Nup of the central channel was shown to be excessively phosphorylated in meningo-virus infected cells displaying loss ofNE permeability function. In fact, in that study, STS was used to block virus-mediated permeabilization of the NE .18 A more likely candidate for mediating nuclear leakiness in our experimental model is gp21O, a large, N-glycosylated integral nuclear membrane protein associated with the NPC via its short C-terminus exposed toward the cytoplasm. The bulk of the protein extends into the lumen of the NE. gp21O, whose cisterna l dom ain possesses five EF hand calcium-binding motives, has been proposed to function as Ca 2 • sensor within the N~, and to mediate Ca 2. -dependent structural changes of the NPC. 24 Moreover, the C-terminal cytoplasmic tail of gp210 is phosphorylated in a cell-cycle dependent manner. 59 gp210 is required for nuclear envelope brea kdown at the onset of mitosis and is possibly involved in ea rly NPC destabilization, functions which depend upon phosphorylation of the C-terminus. 60 Thus, gp210 could potentially respond both to alterations in NE Ca 2 • levels and to the activity of cytosolic kinases . Whether both signaling cues converge onto gp210 and how this affects NPC structure is not known. Interestingly, stable exogenous expression of Bcl-2 in R6 rat fibroblasts which are devoid of the nucleoporin gp210 does not elicit an increase in basal nuclear permeability (data not shown) further supporting a role of gp210 in transducing Ca 2 • signals to the NPC.
So far, the impairment of the permeability barrier function of the NPC has been mostly associated with stress conditions leading to cell demise. T hus, the finding that exogenous Bcl-2 expression, a condition leading to increased survival and stress resistance also increases basal nuclear permeability was unexpected. By showing that these cells possess a reduced steadystate luminal ER [Ca 2 . ], we provide a possible explanation to this seemingly surprising observation . We propose that both, STS treatment as well as Bcl-2 overexpression increase NE permeability via lowering luminal NEIER [Ca 2 .] . Bcl-2 has been shown to localize at the nuclear membrane where it could directly interact with IP3Rs.37.61.63 Importantly, we show that targeting Bcl-2 at the nuclear membrane is sufficient for its permeabilizing activity. Direct binding of Bcl-2 to all three IP3R isoforms has been described. 37 . 64 Recently these interactions have been shown to enha nce the sensitivity of the IP3Rs to IP3 resulting in a decreased steady-state [Ca 2 . ] at the ERY We therefore predict that Bcl-2-IP3R interaction at the nuclear membrane will result in a simi lar reduction of [Ca 2 . ] in the nuclear cisterna. This correlation between ER /N E Ca 2 • levels and NE permeability is in agreement with numerous st udies o n Ca 2 '-mediated structural rearra ngements of the NPC.
Our results cannot exclude the existence of fur·ther mechanisms of NE permeabi lization unrelated to the NPC. High levels of Bcl-2 could destabilize the NE. Alternatively, the marked cytoskeleta l deformations following STS treatment 65 might trigger limited and controlled disruption of the NE . In parvovirusinfected cells such transient NE disruptions were reported to mediate nuclear delivery of the virus. 66 NE deformations involving changes in the phosphorylation status of lamin AIC have been also implicated in SV-40 infection of non-dividing cells. 67 The observation that in STS-treated cells, early nuclear permeabilization can be prevented by BAPTA without affecting final apoptotic execution raises the question about the role of early leakiness of the NE in the apoptotic program . In the presence ofBAPTA, STS-treated cells activate caspases (Fig. 3C) and undergo apoptosis. However, we could not identify nuclei with a morphology correspond ing to stage 3 nuclear apoptosis (nuclear collapse I disassembly)G8 in our confocal movies. In the absence of BAPTA, about 20% of the cells reach this stage within the time of observation (see Fig. 56B ). This finding on the one hand cou ld reflect a requirement for Cal . for completing apoptotic chromatin fragmentation, as already proposed.G 9 On the other hand, it argues against NE dilation being a proapoptotic signal per se. While in the context of apoptosis, early nuclear leakiness might faci litate nuclear disassembly and influence the final apoptotic morphology similarly to what has been reported for the cleavage of B-type lamins,?o it most likely won't interfere with basic cellular functions in a healthy cell. Our observation that signa ldependent nuclear transport remains fully functional during the first phase of STS-mediated nuclear pcrmeabilization coft'oborates this interpretation (data not shown). Our data showing that in tumor cells such as Bcl-2 expressing HeLa and SW480, more than 60% of the cell population shows equal nucleo-cytoplasmic distribution of an inert permeability marker indicate that large variations in the size-exclusion limit of the NE are well tolerated and compatible with cel l survival and proliferation. Large-scale structural rearrangements of'the NPC are known to occur in connection with the passage of very large cargo, such as mRNP particles 7 1 and transient increases in the uptake of transport substrates were observed upon stimulation with growth factors n or 8 during the cell cycle. 'o In bcl-2 overexpressing cells , we observe a constitutive alteration of nuclear membrane permeability which we interpret as an adaptive response to lowered steadystate [Ca 2 ,] in the lumen of the NE. Whether this persistent enhanced accessibility of the nuclear compartment can be established only in the presence of a general death suppressor such as Bcl-2, or whether high NE permeability may promote oncogenic functions of Bcl-2 associated e.g., with cell cycle regulation or DNA repair 73 are challenging questions for the future.
Materials and Methods
Plasmid constructs. p4xCherry was created by consecutively inserting four copies of the cDNA sequence encoding the red fluorescent GFP analog mCherry74 into pcDNA3.1 (Invitrogen) . Removal of the internal start co dons was confirmed by DNA sequence analysis. pRSET-B-mCherry was kindly provided by Roger Tsien (University of California, La Jolla) and used as template for PCR amplification.
Expression constructs encoding murine bcl-2 proteins targeted to different subcellular compartments were a kind gift of Prof. Christoph Borner (University of Freiburg): pcDNA3-mbcl2 (full length murine bcl-2) , pcDNA3 -mbcl2-cytb5 (ER-targeted murine bcl-2) and pcDNA3-mbcl2-RKIChbcl2X1. (mitochondria-targeted murine bcl-2).
The inducible expression construct for NE-targeted murine bcl-2 (NE-Bcl-2) was designed in analogy to a previously described NE-targeted GFP protein . 75 The KASH domain of human Nesprin-2 (aa 6833-6883) was amplified from pEGFP-CI-Tm-Nesprin-2 (kind gift of Dr. Akis Karakesisoglou, University of Durham) by PCR and introduced into the EcoR! and BamHI sites of pTRE MCS (CIon tech) resulting in pTRE-KASH. pTRE-KASH-mBcl-2 was obtained by inserting a mbcl-2 fragment from pcDNA3-mbcl2 lacking the transmembrane domain of bcl-2 into pTRE-KASH. The control plasmid pTRE-GFP-KASH was constructed by insertion of the EGFP coding sequence into pTRE-KASH via PCR.
The p5ERCA2 expression construct was kindly provided by Luca Scorrano (University of Padova, Italy). pNup153-GFP was a kind gift of Jan E llenberg (EMBL Heidelberg). pNup153-D349N-GFP was generated by PCR mutagenesis using the following primers: 153D349NFwd 5'-GTG GGA TAG ATA TCA CAA ATT TTC AGG CCA AAA GAG AAA AG-3' and 153D439NRev 5'-CTT TTC TCT TTT GGC CTG AAA ATT TGT GAT ATC TAT CCC AC-3'.
Cell culture and transfections. HeLa cervix carcinoma cells stably expressing murine bcl-2 (HeLa-mbcl-2) and SW480 colon carcinoma cells stably expressing human Bcl-2 (SW480-hbcl-2) and the respective empty vector control cell lines were a kind gift of Prof. Christoph Borner (University of Freiburg) .
HeLa Tet Off cells expressing the tetracycline controlled transactivator (Clomech) were kindly provided by Dr. Thomas Meergans (Un iversity of Kon stanz).
A ll cell lines were m aintained in DMEM supplemented with 100 U/ml penicillin, 100 f.,lg/ml streptomycin, 2mM L-glutamine (Invitrogen) and 10% fetal calf serum (Sigma). Cells were cu ltivated at 37"C with 5% CO 2 in a humidi fied atmosphere. For live cell microscopy, cells were seeded in glass-bottom dishes (ibidi) and transfected with Effectene (Quiagen) according to the manufacturer's instructions 24 h prior to the experiment.
HeLa Tet Off cells were transfected using the calcium phosphate co-precipitation method. Cells were used for further experiments ~24 h after transfection.
For bead loading experiments, cel ls were seeded in MatTek glass bottom culture dishes wit h a glass inset of ~I cm 2 and grown to a density of ~60% prior to the experiment.
Live cell imaging. Imaging experiments were performed in culture medium devoid of Phenol Red to reduce background fluorescence. After exchanging the medium, 150 fJ..g/ml Hoechst 33342 was added for labeling nuclear DNA, and the cells were incubated at the microscope stage at 37"C and 5% CO 2 for 1-2 h before starting image acquisition. Confocal time-lapse series were recorded at a Zeiss LSM510 Meta confocal microscope equipped with a stage-top incubator and an objective heater using a 63x/1.4 NA Plan-Apochromat objective lens (Carl Zeiss Microimaging). Laser settings were optimized to ensure cell viability for the whole duration of the experiments. As an additional control for phototoxicity, it was verified that imaging conditions were compatible with cell division (Fig. S6A) . Cell nuclei were tracked and focused using an autofocus macro kindly provided by J. E llenberg. For the same reason, automatic segmentation of the cell nucleus in the Hoechst channel was not app licable. Therefore, all three channels were segmented interactively. Nuclear condensation and NE permeabilization were measured in the Hoechst and the 4xCherry channel, resp ectively. To this end, a ROI corresponding [Q the inner boundary of the nucleus was first defined in the NupI53-GFP channel and copied into the Hoechst and the 4xCherry images. For quantifying NE integrity, signal intensities were measured in the NupI53-GFP channel in a second ROI including the nuclear rim (Fig. SID) . Folded regions of the NE were omitted. Intensity values were background substracted, corrected for bleaching, and normalized. The ti~e point of nuclear condensation in each time series was defined as an increase in Hoechst fluorescence by a factor of at least 1.07 occurrin g within two consecutive frames. Cells go through apoptosis asynchronously. To better visualize the abrupt changes in nuclear permeability and NE integrity occurring at the final stage of nuclear execution, intensity values for these two channels were plotted on two separate time-axis. In the first part of the time course intensity values were displayed from the start of image acquisition up to the time point immediately preceding nuclear condensation. In the second parr, traces were aligned with respect to the t ime point of chromatin condensation as determined in the Hoechst channel.
Assessment of nuclear permeability. Nuclear Permeability Assay (NPA) was performed as described previously.43 Briefly, cells were seeded onto glass coverslips ~20 h before the start of the experiment. Cell membranes were selectively permeabilized with digitonin (24 fJ..g/ml). The semi-permeabilized cells were incubated with the fluorescent permeability marker 70 kDa Texas Red-labeled dextran (Sigma) at a concentration of 20 mg/ ml and then imaged at the confocal microscope (Zeiss LSM510 Meta). Images were quantitated semi-automatically by a custommade software extracting the average nuclear fluorescence intensity. Fluorescence intensity in the nucleus is a measure of nuclear penetration of 70 kDa dextran and thus an indicator of passive permeability of the nuclear envelope.
For the experiment shown in Figure S3B cells were loaded with 70 kDa Texas Red-labeled dextran using glass beads.77.78 Briefly, glass beads with a diameter of ~100 fJ..m (Sigma) were treated overnight with 5 M NaOH, washed with ethanol and dried by evaporation. The culture medium was removed and 20 fJ..I dextran solution was added to the glass inset ofMatTek culture dishes (20 mg/ml 70 kDa Texas Red-labeled dextran (Sigma) in PBS). Subsequently, a monolayer of clean glass beads was added into the dish cavity and the dish was quickly shaken. Beads were then removed by washing with PBS, medium added back and the cel ls incubated for 45 min at 37"C. Confocal images were taken and evaluated as described above.
In cells expressing Bcl-2 and its mutants, nuclear permeability was assessed by measuring the percentage of cells displaying nuclear lo ca lization of 4xCherry. Images were taken at fixed time points after transfection of 4xCherry and Bcl-2 expression contructs by confocal fluorescence microscopy. Only cells showing at least the same 4xCherry signal in the nucleus as in the cytosol were scored as having a nuclear 4xCherry localization.
Immunocytochemistry. Immunocytochemical detection of mbcl-2 was performed using antib odies specific for murine bcl-2 (mouse monoclonal anti-bcl-2 clone lOC4, Santa Cruz), at a dilution of 1 :500 in 10% NGS/PBS . Cells were shortly washed with 5 mM MgCI/PBS, permeabilised with 0.3% digitonin/PBS for 5 min on ice and rinsed again in 5 mM MgCI/PBS. Fixation was performed with 4% PFA/PBS for 10 min at room temperature followed by washing in PBS. Reactive aldehyde groups were blocked ~ith 50 mM NH 4 C I for 10 min. Unspecific binding sites were saturated with 1 % BSA/PBS for 30 min . Incubation with the IOC4 anti-bcl-2 antibody was overnight at 4°C. The secondary antibody conjugated to Alexa488 (Molecular Probes) was min. Antibody incubations and Hoechst staini ng of DNA were performed as described above.
Immunostaining of Bcl-2 at the nuclear membrane required a permeabilization step prior to fixation and was therefore not compatible with simultaneous detection of 4xCherry. In this case, the protocol used for co-detection of 4xCherry and Bcl-2 resulted in a punctuate staining pattern that nevertheless allowed for the identification of cotransfected cells and image quantification . The correct locali zation of NE-Bcl-2 was confirmed in parallel transfections using digitonin permeabilization.
For co-detection of 4xCherry and SERCA2, cells were fixed overnight at 4°C in 4% PFA/PBS and processed as decribed above with omission of the acetone treatment. The SERCA2 antibody (lI08, Alexis) was diluted 1 :750 in 1 % BSA/PBS.
Preparation of whole cell extracts and immunoblot analysis. For the preparation of cell Iysates, HeLa cell cultures were placed on ice, and protease inhibitors (Complete Mix; Roche Applied Science) and dithiothreitol (lmM) were added directly to the growth media. The cells were then gently scraped off the dish with a rubber policeman, washed in ice-cold PBS, resuspended in 95°C lysis buffer (50 mM Tris/HCI, pH 8.0, 0.5% SOS, 1 mM dithiothreitol), and heated at 95°C for 10 min. The cell debris was removed by centrifugation at 20,000 x g for 10 min. For the detection of Nup-153, SOS-PAGE was performed according to Thomas and Kornberg,79 while for other proteins it was according to Laemmli. 80 Proteins were blotted onto nitrocellullose using a wet blot chamber (Bio-Rad Trans-Blot Cell) or a Semidry Blotter (Biometra), and filters incubated in TNT buffer (50 mM Tris, pH 8.0, 150 mM NaCI, 0.05% Tween 20) with 5% milk powder at room temperature for 1 h. Incubation with primary antibodies at 4°C was in TNT with milk overnight. Fi lter washings were in TNT alone. Incubations with horseradish peroxidase-coupled secondary antibodies (I :2000, Oako) were in TNT with milk at room temperature for 1 h. The filter strip with the biotinylated molecular weight marker (Bio-Rad) was incubated separately with horseradish peroxidase-coupled avidin for 30 min at room temperature. Immunoblots were visualized with a chem iluminescent image ana lyzer (LAS-lOOO; Fujifi lm ) . Murine and human Bcl-2 were detected using the antibody NI9 (Santa Cruz) at a dilution of I :2000. The anti-actin antibody (Chemicon) was used at I :50000 dilution, the anti-Nup-153 I GFP antibody (Progen, clone nup7A8) at I :50 dilution, and the anti-OsRed antibody (Clontech) at 1:500 dilution.
Fluorometric determination of protease activity, and of
ER/N E [Ca h ]
. For measurement of caspase activity, a total of 3 x 10 5 HeLa cells were seeded in six-well plates 24 h prior to 10 the experiment and treated with STS (0.5 110m). To block caspase activation zVAO-fmk (20 110M) was added 30 min prior apoptotic stimulation At the indicated time points, the cells were placed on ice and after the addition of protease inhibitors, they were gently scraped off the dish and collected by centrifugation. Cells were lysed in 25 mM HEPES, pH 7.5, 5 mM MgCI 2 , I mM EGTA, and 0.5% Triton X-lOO, and the cleavage of OEVO-7-amino-4-trifl uoromethyl coumarin (afc) (40 110M) was monitored fluorometrically in reaction buffer (50 mM HEPES, pH 7.5, 10 mM dithiothreitol, 1% sucrose, 0.1 % CHAPS {3-[(3-cholamidopropyl)-dimethyla' mmonio] -2-hydroxy-I-propanesulfonate)) over a period of 20 min at 37°C, with a \ , (excitation wavelength) value of 390 nm and a A"n (emission wavelength) value of 505 nm. The activity was ca librated by using afc standard solutions. Measurements were run in triplicate.
Calpain activity was measured using a Calpain Activity Assay Kit (Abcam, ab65308) according to the manufacturer's instructions. For apoptosis induction, HeLa cells were treated with 0.5 110M STS for 2h. To block calpain activity, 5 110M calpeptin (Merck) was added 30 min prior to STS treatment. Cell Iysates were prepared from 2 x lOG cells. Protein concentrations were determined using BCA (Pierce Biotechnology). Lysates were spiked with 10 110M 1101 active calpain. After add ition of the calpain substrate (Ac-LLY-afc), samples were transferred to a black UV-light permeable 96-well plate and incubated at 37°C for 60 min. Fluorescence emission of afc was detected as above. 
